Biotech entity
All 1 tracked stories fall under one category: pharma. DA Davidson is most often covered alongside Agenus Inc., which appears in 1 of these 1 story. We currently track 1 Biotech story that mention DA Davidson, all published on August 8, 2026.
Last mentioned: Aug 8, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. DA Davidson is most often covered alongside Agenus Inc., which appears in 1 of these 1 story. We currently track 1 Biotech story that mention DA Davidson, all published on August 8, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering DA Davidson. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen upgraded biotech Agenus to buy despite a massive Q1 earnings miss, as the stock surged 189% from its 52-week low. Mixed analyst views and a $30 HC Wainwright target highlight the speculative upside in immuno-oncology.
Source: tickerreport.com · dailypolitical.com
DA Davidson is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
